InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（9 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
9
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by O'Brien Patrick, 首席运营官. Director active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 21 disclosures have been logged. Split: 0 buy · 9 sells. Total volume traded: €1.9m. History available since 31 December 2021. The latest transaction was filed on 13 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to O'Brien Patrick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
3,026 股ORDINARY SHARESSEC:0001385613-26-000082:0
9,273 股0ORDINARY SHARESSEC:0001385613-26-000039:0
31,961 股0ORDINARY SHARESSEC:0001385613-26-000012:0
540 股0Common StockSEC:0001627183-26-000003:0
560 股0Common StockSEC:0001627183-26-000001:0
7,500 股@ US$13.48100.0% 占其流量ORDINARY SHARESSEC:0001385613-25-000067:0
9,389 股0ORDINARY SHARESSEC:0001385613-25-000032:0
29,277 股0ORDINARY SHARESSEC:0001385613-25-000026:0
19,658 股@ US$19.6912.5% 占其流量Common StockSEC:0001628280-25-000806:1
100,000 股0Common StockSEC:0001628280-25-000806:0
9,526 股@ US$20.106.2% 占其流量Common StockSEC:0001628280-25-000806:2
8,000 股@ US$19.695.0% 占其流量Common StockSEC:0001628280-25-000806:3
8,489 股0ORDINARY SHARESSEC:0001385613-24-000026:0
3,849 股@ US$31.833.7% 占其流量Common StockSEC:0001628280-24-000744:0
9,413 股0CLASS A ORDINARY SHARESSEC:0001385613-23-000032:0
7,500 股@ US$37.398.8% 占其流量Common StockSEC:0001209191-23-002481:0
2,653 股@ US$37.533.1% 占其流量Common StockSEC:0001209191-23-002114:0
32,000 股@ US$6.156.2% 占其流量Common StockSEC:0001209191-22-062530:0
16,781 股0CLASS A ORDINARY SHARESSEC:0001385613-22-000049:0
12,434 股@ US$60.490.0062% mcap40.7% 占其流量Common StockSEC:0001209191-22-002599:0
28,000 股@ US$6.150.0014% mcap9.3% 占其流量Common StockSEC:0001209191-22-001308:0
21 条申报中的 21 条
About O'Brien Patrick
Patrick O'Brien serves as Chief Operating Officer and General Counsel at ARROWHEAD PHARMACEUTICALS, INC. He oversees the daily operations of the company while ensuring legal and regulatory compliance. Patrick brings valuable expertise in risk management and business strategy, contributing to Arrowhead's mission of developing innovative therapies. His role is essential in ensuring operational efficiency and protecting the company's interests.
